elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38170188-A571A16B-2329-4D63-8053-E93AB21F4D04
Q38170188-A571A16B-2329-4D63-8053-E93AB21F4D04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38170188-A571A16B-2329-4D63-8053-E93AB21F4D04
MmpL3 a potential new target for development of novel anti-tuberculosis drugs.
P2860
Q38170188-A571A16B-2329-4D63-8053-E93AB21F4D04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38170188-A571A16B-2329-4D63-8053-E93AB21F4D04
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2eda67e52ea5806d866982a36878d9a2668fd6c7
P2860
Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis